NASDAQ:DERM Journey Medical (DERM) Stock Price, News & Analysis $6.22 +0.16 (+2.64%) Closing price 04:00 PM EasternExtended Trading$6.23 +0.01 (+0.16%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Journey Medical Stock (NASDAQ:DERM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Journey Medical alerts:Sign Up Key Stats Today's Range$6.08▼$6.2950-Day Range$4.39▼$6.9152-Week Range$4.31▼$9.56Volume125,517 shsAverage Volume207,665 shsMarket Capitalization$171.24 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingHold Company Overview Journey Medical Corp, headquartered in Fairfield, New Jersey, is a commercial dermatology company focused on acquiring, developing and marketing prescription dermatology products in the United States. Since its incorporation in 2019, the company has built a portfolio of both branded and generic topical therapies designed to address a range of skin conditions, including acne, atopic dermatitis, fungal infections and inflammatory lesions. The company’s product lineup features antibiotic/anti-inflammatory combinations and corticosteroid-based formulations delivered through proprietary gel, cream and foam vehicles. Journey Medical leverages an in-house commercial infrastructure, including a specialized sales force and key partnerships with pharmacies and distributors, to reach dermatology practices and healthcare providers nationwide. Underpinning its growth strategy is an acquisition-driven approach that targets established, off-patent dermatology assets with stable prescription demand. The company’s management team, comprised of executives with deep experience in pharmaceutical marketing and specialty drug launches, continues to screen for complementary assets to expand its addressable market and enhance shareholder value.AI Generated. May Contain Errors. Read More Journey Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreDERM MarketRank™: Journey Medical scored higher than 61% of companies evaluated by MarketBeat, and ranked 342nd out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingJourney Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialJourney Medical has a consensus price target of $13.00, representing about 109.0% upside from its current price of $6.22.Amount of Analyst CoverageJourney Medical has only been the subject of 2 research reports in the past 90 days.Read more about Journey Medical's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth752.94% Earnings GrowthEarnings for Journey Medical are expected to grow by 752.94% in the coming year, from $0.17 to $1.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Journey Medical is -16.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Journey Medical is -16.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJourney Medical has a P/B Ratio of 6.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Journey Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted14.93% of the float of Journey Medical has been sold short.Short Interest Ratio / Days to CoverJourney Medical has a short interest ratio ("days to cover") of 11.39, which indicates bearish sentiment.Change versus previous monthShort interest in Journey Medical has recently decreased by 5.62%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJourney Medical does not currently pay a dividend.Dividend GrowthJourney Medical does not have a long track record of dividend growth. News and Social Media2.5 / 5News SentimentN/A News SentimentJourney Medical has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Journey Medical this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for DERM on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Journey Medical insiders have not sold or bought any company stock.Percentage Held by Insiders15.03% of the stock of Journey Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.25% of the stock of Journey Medical is held by institutions.Read more about Journey Medical's insider trading history. Receive DERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DERM Stock News HeadlinesHow The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation TargetJune 3 at 7:39 PM | uk.finance.yahoo.comJourney Medical Highlights EMROSI Momentum, Coverage Gains and 2026 Launch PlansMay 25, 2026 | americanbankingnews.comRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.June 4 at 1:00 AM | Porter & Company (Ad)Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare ConferenceMay 20, 2026 | markets.businessinsider.comJourney Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare ConferenceMay 19, 2026 | globenewswire.comJourney Medical Rides Emrosi Surge in Earnings CallMay 14, 2026 | tipranks.comJourney Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...May 14, 2026 | finance.yahoo.comTranscript: Journey Medical Q1 2026 Earnings Conference CallMay 14, 2026 | finance.yahoo.comSee More Headlines DERM Stock Analysis - Frequently Asked Questions How have DERM shares performed this year? Journey Medical's stock was trading at $7.71 on January 1st, 2026. Since then, DERM stock has decreased by 19.3% and is now trading at $6.22. How were Journey Medical's earnings last quarter? Journey Medical Corporation (NASDAQ:DERM) posted its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.01. The business had revenue of $15.96 million for the quarter, compared to the consensus estimate of $15.47 million. Journey Medical had a negative trailing twelve-month return on equity of 35.57% and a negative net margin of 14.82%. Read the conference call transcript. When did Journey Medical IPO? Journey Medical (DERM) raised $39 million in an initial public offering on Friday, November 12th 2021. The company issued 3,520,000 shares at a price of $10.00-$12.00 per share. Who are Journey Medical's major shareholders? Journey Medical's top institutional shareholders include Wasatch Advisors LP (7.81%), Pale Fire Capital SE (1.76%), Lazard Asset Management LLC (0.16%) and Bank of New York Mellon Corp (0.14%). Insiders that own company stock include Claude Maraoui, Ramsey Alloush, Lindsay A Md Rosenwald, Justin Adam Smith and Joseph Benesch. View institutional ownership trends. How do I buy shares of Journey Medical? Shares of DERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Journey Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Journey Medical investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), ServiceNow (NOW), Adobe (ADBE) and AppLovin (APP). Company Calendar Last Earnings5/13/2026Today6/04/2026Next Earnings (Estimated)8/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 3 weeks, DERM's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:DERM Previous SymbolNASDAQ:DERM CIK1867066 Webjourneymedicalcorp.com Phone480-434-6670FaxN/AEmployees90Year Founded2014Price Target and Rating Average Price Target for Journey Medical$13.00 High Price Target$13.00 Low Price Target$13.00 Potential Upside/Downside+109.0%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.37) Trailing P/E RatioN/A Forward P/E Ratio36.59 P/E GrowthN/ANet Income-$11.43 million Net Margins-14.82% Pretax Margin-14.73% Return on Equity-35.57% Return on Assets-10.88% Debt Debt-to-Equity Ratio0.74 Current Ratio1.72 Quick Ratio1.47 Sales & Book Value Annual Sales$61.86 million Price / Sales2.77 Cash FlowN/A Price / Cash FlowN/A Book Value$0.96 per share Price / Book6.48Miscellaneous Outstanding Shares27,530,000Free Float23,396,000Market Cap$171.24 million OptionableN/A Beta1.09 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:DERM) was last updated on 6/4/2026 by MarketBeat.com Staff. From Our PartnersA New Approach to Affordable Housing75% of U.S. households cannot afford a median-priced new home. BOXABL's factory-built, foldable homes are desi...BOXABL | SponsoredTrump’s secret China dealTrump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, J...Porter & Company | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredThe chokepoint supplier behind SpaceX's $1.75 trillion empireWhen Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...Behind the Markets | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredWhere did Vanguard quietly put $101 billion?Tech investor George Gilder spent 40 years identifying paradigm shifts before they went mainstream - flagging ...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
